Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT02575560 · COMPLETED

Trial details

NCT number: NCT02575560
Sponsor: Qingdao Central Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

EGFR-TKI Resistant Mutation

Start date: 2015-10-01
Primary completion: 2017-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.